Disclosures:
Disclosure of Conflicts of Interest:
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.
| Beth Faiman PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO |
Beth Faiman has disclosed that she received consulting fees from BMS, GSK, Janssen, Karyopharm, Pfizer, and Sanofi. |
| Kevin Brigle PhD, NP |
Kevin Brigle has disclosed that he received speaking honoraria from AbbVie, Astra Zeneca, BMS, Janssen, Karyopharm, Sanofi Genzyme, and Takeda. |
| Donna D. Catamero ANP-BC, OCN®, CCRC |
Donna Catamero has disclosed that she received speaking honoraria from BMS and Johnson & Johnson, and consulting fees from BMS, Johnson & Johnson, Legend Biotech, and Pfizer. |
| Patricia A. Mangan RN, MSN, APRN-BC |
Patricia Mangan has disclosed that she received speaking honoraria from BMS, GSK, Janssen, Karyopharm, Sanofi, and Takeda, and consulting fees from BMS, GSK, and Janssen. |
The staff reported the following relevant financial relationships they have with ineligible companies related to the content of this activity:
| Diane Moran RN, MA, EdM |
Diane Moran has no relevant financial relationships to report. |
| Michelle Faber MS |
Michelle Faber has no relevant financial relationships to report. |
| Joyce Divine PhD, MBA |
Joyce Divine has no relevant financial relationships to report. |
All of the relevant financial relationships listed for these individuals have been mitigated.
The PIM planners and others have nothing to disclose.
Off-label use of drugs may be discussed.